ChemMedChem | 2021
Synthesis and Assessment of Fused β‐Carboline Derivatives as Kappa Opioid Receptor Agonists
Abstract
The synthesis of 5‐formyl‐6‐aryl‐6H‐indolo[3,2,1‐de][1,5] naphthyridine‐2‐carboxylates by reaction between 1‐formyl‐9H‐β‐carbolines and cinnamaldehydes in the presence of pyrrolidine in water with microwave irradiation is described. Pharmacophoric modification of the formyl group offered several new fused β‐carboline derivatives, which were investigated for their κ‐opioid receptor (KOR) agonistic activity. Two compounds 4\u2009a and 4\u2009c produced appreciable agonist activity on KOR with EC50 values of 46±19 and 134±9\u2005nM, respectively. Moreover, compound‐induced KOR signaling studies suggested both compounds to be extremely G‐protein‐biased agonists. The analgesic effect of 4\u2009a was validated by the increase in tail flick latency in mice in a time‐dependent manner, which was completely blocked by the KOR‐selective antagonist norBNI. Moreover, unlike U50488, an unbiased full KOR agonist, 4\u2009a did not induce sedation. The docking of 4\u2009a with the human KOR was studied to rationalize the result.